J
Jiangsu Hualan New Pharmaceutical Material Co Ltd
SZSE:301093
Jiangsu Hualan New Pharmaceutical Material Co Ltd
SZSE:301093
Price:
77.49
CNY
0.25%
Market Closed
Market Cap:
¥12.7B
Income Statement
Earnings Waterfall
Jiangsu Hualan New Pharmaceutical Material Co Ltd
Jiangsu Hualan New Pharmaceutical Material Co Ltd
Income Statement
Jiangsu Hualan New Pharmaceutical Material Co Ltd
Jiangsu Hualan New Pharmaceutical Material Co Ltd
Currency: CNY
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
5
|
6
|
6
|
5
|
3
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
615
N/A
|
633
+3%
|
784
+24%
|
821
+5%
|
784
-5%
|
691
-12%
|
586
-15%
|
584
0%
|
610
+4%
|
619
+2%
|
631
+2%
|
623
-1%
|
593
-5%
|
604
+2%
|
592
-2%
|
586
-1%
|
605
+3%
|
611
+1%
|
605
-1%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(324)
|
(306)
|
(361)
|
(371)
|
(369)
|
(351)
|
(329)
|
(332)
|
(352)
|
(356)
|
(363)
|
(365)
|
(362)
|
(374)
|
(369)
|
(362)
|
(378)
|
(381)
|
(378)
|
|
| Gross Profit |
291
N/A
|
327
+12%
|
422
+29%
|
450
+6%
|
414
-8%
|
341
-18%
|
257
-25%
|
252
-2%
|
258
+2%
|
263
+2%
|
268
+2%
|
258
-4%
|
232
-10%
|
230
-1%
|
223
-3%
|
225
+0%
|
228
+1%
|
230
+1%
|
227
-1%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(134)
|
(137)
|
(160)
|
(195)
|
(187)
|
(177)
|
(170)
|
(183)
|
(180)
|
(185)
|
(180)
|
(173)
|
(172)
|
(165)
|
(172)
|
(188)
|
(181)
|
(184)
|
(186)
|
|
| Selling, General & Administrative |
(108)
|
(110)
|
(129)
|
(144)
|
(144)
|
(138)
|
(131)
|
(132)
|
(151)
|
(158)
|
(164)
|
(132)
|
(145)
|
(138)
|
(131)
|
(129)
|
(146)
|
(148)
|
(149)
|
|
| Research & Development |
(31)
|
(31)
|
(37)
|
(41)
|
(44)
|
(41)
|
(39)
|
(34)
|
(36)
|
(37)
|
(36)
|
(33)
|
(39)
|
(38)
|
(40)
|
(36)
|
(38)
|
(38)
|
(40)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
2
|
3
|
4
|
2
|
1
|
2
|
(0)
|
3
|
7
|
9
|
20
|
17
|
11
|
11
|
(1)
|
6
|
3
|
2
|
3
|
|
| Operating Income |
156
N/A
|
189
+21%
|
262
+39%
|
255
-3%
|
227
-11%
|
164
-28%
|
87
-47%
|
69
-20%
|
78
+13%
|
78
-1%
|
89
+14%
|
86
-3%
|
59
-31%
|
65
+10%
|
52
-20%
|
37
-29%
|
47
+28%
|
46
-2%
|
41
-10%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
(10)
|
(9)
|
(7)
|
(0)
|
14
|
27
|
38
|
42
|
35
|
38
|
35
|
53
|
53
|
46
|
44
|
25
|
24
|
23
|
20
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
1
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(1)
|
|
| Pre-Tax Income |
146
N/A
|
179
+23%
|
253
+41%
|
253
0%
|
240
-5%
|
189
-21%
|
122
-35%
|
107
-12%
|
110
+2%
|
112
+2%
|
122
+8%
|
137
+13%
|
111
-19%
|
109
-1%
|
93
-15%
|
59
-37%
|
68
+16%
|
66
-3%
|
60
-9%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(23)
|
(28)
|
(40)
|
(37)
|
(34)
|
(25)
|
(14)
|
(14)
|
(14)
|
(15)
|
(15)
|
(19)
|
(15)
|
(15)
|
(12)
|
(9)
|
(10)
|
(10)
|
(9)
|
|
| Income from Continuing Operations |
122
|
151
|
213
|
216
|
206
|
164
|
108
|
94
|
96
|
98
|
106
|
118
|
95
|
95
|
81
|
50
|
57
|
56
|
51
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
122
N/A
|
151
+23%
|
213
+41%
|
216
+1%
|
206
-5%
|
164
-20%
|
108
-34%
|
94
-13%
|
96
+2%
|
98
+2%
|
106
+9%
|
118
+11%
|
95
-19%
|
95
-1%
|
81
-15%
|
50
-39%
|
57
+16%
|
56
-2%
|
51
-10%
|
|
| EPS (Diluted) |
0.69
N/A
|
0.86
+25%
|
1.21
+41%
|
1.23
+2%
|
1.17
-5%
|
0.93
-21%
|
0.61
-34%
|
0.54
-11%
|
0.54
N/A
|
0.55
+2%
|
0.6
+9%
|
0.67
+12%
|
0.55
-18%
|
0.58
+5%
|
0.47
-19%
|
0.3
-36%
|
0.34
+13%
|
0.34
N/A
|
0.31
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
